Health ❯ Healthcare ❯ Drug Development

Regulatory Approval

Clinical Research FDA Submissions Anvisa Clinical Trials FDA Approval Clinical Use Accelerated Approval Clinical Studies New Antibiotics European Medicines Agency

3 ARTICLES

last wk.

EU Regulators Back AstraZeneca’s Trixeo for Asthma

European regulators will now decide whether to add a single‑inhaler triple‑therapy option for adolescents and adults not controlled on medium‑dose ICS/LABA.

6 ARTICLES

8mo ago

Sorfequiline Outperforms Standard TB Regimens in Phase 2 Trial

3 ARTICLES

9mo ago

CHMP Recommends Approval of Wayrilz for Refractory ITP in Adults

4 ARTICLES

last yr.

AstraZeneca’s Baxdrostat Delivers Significant Blood Pressure Reductions in Phase 3 Trial for Resistant Hypertension

8 ARTICLES

last yr.

Novo Nordisk's CagriSema Falls Short in Latest Weight-Loss Trial for Diabetes Patients